TF and Alzheimer disease: While the fluid biomarker studies above generally showed decreased levels of iron-related proteins, a study examining ceruloplasmin to transferrin ratio in serum found that transferrin saturation, and not transferrin itself, actually increased in AD patients (Squitti et al., 2011).